|
Orthologous residues
|
|
IPMK (human): Y191‑p, IPMK (mouse): Y174‑p, IPMK (rat): Y174‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site
|
|
Relevant cell lines - cell types - tissues:
GT1-7 (neuron)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
glucose
|
|
|
|
increase
|
high glucose
|
|
low glucose
|
|
|
|
decrease
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
AMPKA2 (mouse)
|
|
Induces
|
phosphorylation
|
|
co-immunoprecipitation
|
|